Delivery of peptide coacervates to form stable interaction hubs in cells

Posted on
delivery-of-peptide-coacervates-to-form-stable-interaction-hubs-in-cells
Delivery of peptide coacervates to form stable interaction hubs in cells

References

  1. Sadelain, M., Rivière, I. & Riddell, S. Therapeutic T cell engineering. Nature 545, 423–431 (2017).

    Google Scholar 

  2. Lim, W. A. & June, C. H. The principles of engineering immune cells to treat cancer. Cell 168, 724–740 (2017).

    Google Scholar 

  3. Chen, Z. & Elowitz, M. B. Programmable protein circuit design. Cell 184, 2284–2301 (2021).

    Google Scholar 

  4. Pawson, T. & Scott, J. D. Signaling through scaffold, anchoring, and adaptor proteins. Science 278, 2075–2080 (1997).

    Google Scholar 

  5. Good, M. C., Zalatan, J. G. & Lim, W. A. Scaffold proteins: hubs for controlling the flow of cellular information. Science 332, 680–686 (2011).

    Google Scholar 

  6. Banani, S. F., Lee, H. O., Hyman, A. A. & Rosen, M. K. Biomolecular condensates: organizers of cellular biochemistry. Nat. Rev. Mol. Cell Biol. 18, 285–298 (2017).

    Google Scholar 

  7. Garabedian, M. V. et al. Designer membraneless organelles sequester native factors for control of cell behavior. Nat. Chem. Biol. 17, 998–1007 (2021).

    Google Scholar 

  8. Schuster, B. S. et al. Controllable protein phase separation and modular recruitment to form responsive membraneless organelles. Nat. Commun. 9, 2985 (2018).

    Google Scholar 

  9. McBride, H. M., Neuspiel, M. & Wasiak, S. Mitochondria: more than just a powerhouse. Curr. Biol. 16, R551–R560 (2006).

    Google Scholar 

  10. Boulon, S., Westman, B. J., Hutten, S., Boisvert, F.-M. & Lamond, A. I. The nucleolus under stress. Mol. Cell 40, 216–227 (2010).

    Google Scholar 

  11. Lafontaine, D. L. J., Riback, J. A., Bascetin, R. & Brangwynne, C. P. The nucleolus as a multiphase liquid condensate. Nat. Rev. Mol. Cell Biol. 22, 165–182 (2021).

    Google Scholar 

  12. Mitrea, D. M. et al. Nucleophosmin integrates within the nucleolus via multi-modal interactions with proteins displaying R-rich linear motifs and rRNA. eLife 5, e13571 (2016).

  13. Protter, D. S. W. & Parker, R. Principles and properties of stress granules. Trends Cell Biol. 26, 668–679 (2016).

    Google Scholar 

  14. Li, P. et al. Phase transitions in the assembly of multi-valent signaling proteins. Nature 483, 336–340 (2012).

    Google Scholar 

  15. Banjade, S. & Rosen, M. K. Phase transitions of multivalent proteins can promote clustering of membrane receptors. eLife 3, e04123 (2014).

    Google Scholar 

  16. Huang, W. Y. C. et al. A molecular assembly phase transition and kinetic proofreading modulate Ras activation by SOS. Science 363, 1098–1103 (2019).

    Google Scholar 

  17. Yoshizawa, T., Nozawa, R.-S., Jia, T. Z., Saio, T. & Mori, E. Biological phase separation: cell biology meets biophysics. Biophys. Rev. 12, 519–539 (2020).

    Google Scholar 

  18. Langdon, E. M. & Gladfelter, A. S. A new lens for RNA localization: liquid-liquid phase separation. Annu. Rev. Microbiol. 72, 255–271 (2018).

    Google Scholar 

  19. Dzuricky, M., Rogers, B. A., Shahid, A., Cremer, P. S. & Chilkoti, A. De novo engineering of intracellular condensates using artificial disordered proteins. Nat. Chem. 12, 814–825 (2020).

    Google Scholar 

  20. Sang, D. et al. Condensed-phase signaling can expand kinase specificity and respond to macromolecular crowding. Mol. Cell 82, 3693–3711.e10 (2022).

    Google Scholar 

  21. Piovesan, D. et al. MobiDB: 10 years of intrinsically disordered proteins. Nucleic Acids Res. 51, D438–D444 (2023).

    Google Scholar 

  22. Zhao, E. M. et al. Light-based control of metabolic flux through assembly of synthetic organelles. Nat. Chem. Biol. 15, 589–597 (2019).

    Google Scholar 

  23. Dou, Y. et al. The CAG promoter maintains high-level transgene expression in HEK293 cells. FEBS Open Bio. 11, 95–104 (2021).

    Google Scholar 

  24. Mitchell, M. J. et al. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 20, 101–124 (2021).

    Google Scholar 

  25. Müller, J. A. et al. Kinetics of RNA-LNP delivery and protein expression. Eur. J. Pharm. Biopharm. 197, 114222 (2024).

    Google Scholar 

  26. Guidotti, G., Brambilla, L. & Rossi, D. Cell-penetrating peptides: from basic research to clinics. Trends Pharmacol. Sci. 38, 406–424 (2017).

    Google Scholar 

  27. Lindgren, M. et al. Cell-penetrating peptides. Trends Pharmacol. Sci. 21, 99–103 (2000).

    Google Scholar 

  28. Koren, E. & Torchilin, V. P. Cell-penetrating peptides: breaking through to the other side. Trends Mol. Med. 18, 385–393 (2012).

    Google Scholar 

  29. Sun, Y. et al. Phase-separating peptides for direct cytosolic delivery and redox-activated release of macromolecular therapeutics. Nat. Chem. 14, 274–283 (2022).

    Google Scholar 

  30. Cao, S. et al. Dipeptide coacervates as artificial membraneless organelles for bioorthogonal catalysis. Nat. Commun. 15, 39 (2024).

    Google Scholar 

  31. Lim, J. et al. Liquid–liquid phase separation of short histidine- and tyrosine-rich peptides: sequence specificity and molecular topology. J. Phys. Chem. B 125, 6776–6790 (2021).

    Google Scholar 

  32. Shebanova, A. et al. Cellular uptake of phase-separating peptide coacervates. Adv. Sci. 11, 2402652 (2024).

    Google Scholar 

  33. Sun, Y. et al. Redox-responsive phase-separating peptide as a universal delivery vehicle for CRISPR/Cas9 genome editing machinery. ACS Nano 17, 16597–16606 (2023).

    Google Scholar 

  34. Sun, Y. et al. Phase-separating peptide coacervates with programmable material properties for universal intracellular delivery of macromolecules. Nat. Commun. 15, 10094 (2024).

    Google Scholar 

  35. Gudlur, S. et al. pH-dependent interactions of coacervate-forming histidine-rich peptide with model lipid membranes. Front. Soft Matter 3, 1339496 (2024).

  36. Bentley, E. P., Frey, B. B. & Deniz, A. A. Physical chemistry of cellular liquid-phase separation. Chem. – A Eur. J. 25, 5600–5610 (2019).

    Google Scholar 

  37. Kubala, M. H., Kovtun, O., Alexandrov, K. & Collins, B. M. Structural and thermodynamic analysis of the GFP:GFP-nanobody complex. Protein Sci. 19, 2389–2401 (2010).

    Google Scholar 

  38. Lim, J. et al. Hierarchical structural organization in bioinspired peptide coacervate microdroplets. ACS Nano 19, 35724–35739 (2025).

  39. Wadia, J. S., Stan, R. V. & Dowdy, S. F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10, 310–315 (2004).

    Google Scholar 

  40. Uz, M., Bulmus, V. & Alsoy Altinkaya, S. Comparison of cell-penetrating and fusogenic TAT-HA2 peptide performance in peptideplex, multicomponent, and conjugate siRNA delivery systems. ACS Omega 9, 47461–47474 (2024).

    Google Scholar 

  41. Wang, Y., Ukwattage, V., Xiong, Y. & Such, G. K. Advancing endosomal escape of polymeric nanoparticles: towards improved intracellular delivery. Mater. Horiz. 12, 3622–3632 (2025).

    Google Scholar 

  42. Beach, M. A. et al. Quantifying the endosomal escape of pH-responsive nanoparticles using the split luciferase endosomal escape quantification assay. ACS Appl. Mater. Interfaces 14, 3653–3661 (2022).

    Google Scholar 

  43. Debisschop, A., Bogaert, B., Muntean, C., De Smedt, S. C. & Raemdonck, K. Beyond chloroquine: cationic amphiphilic drugs as endosomal escape enhancers for nucleic acid therapeutics. Curr. Opin. Chem. Biol. 83, 102531 (2024).

    Google Scholar 

  44. Wang, H. et al. Beyond canonical PROTAC: biological targeted protein degradation (bioTPD). Biomater. Res. 27, 72 (2023).

    Google Scholar 

  45. Chan, A. et al. Lipid-mediated intracellular delivery of recombinant bioPROTACs for the rapid degradation of undruggable proteins. Nat. Commun. 15, 5808 (2024).

    Google Scholar 

  46. Yu, X. et al. Phase separation enhanced PROTAC for highly efficient protein degradation. Biomacromolecules 25, 4374–4383 (2024).

    Google Scholar 

  47. Lim, S. et al. bioPROTACs as versatile modulators of intracellular therapeutic targets including proliferating cell nuclear antigen (PCNA). Proc. Natl. Acad. Sci. USA 117, 5791–5800 (2020).

    Google Scholar 

  48. Welles, R. M. et al. Determinants that enable disordered protein assembly into discrete condensed phases. Nat. Chem. 16, 1062–1072 (2024).

    Google Scholar 

Download references